Fig. 3
Expression of circARID1A in GC and associated clinical characteristics. A CircARID1A levels in GC tissues and paired adjacent tissues (n = 21). B ISH analysis of circARID1A expression in TMA of GC patients (adjacent tissues = 86 cases; GC tissues = 94 cases). C ISH analysis of circARID1A expression in GC patients with stage I and stage II-IV. D ISH analysis of circARID1A expression in GC patients with stage TI + TII and stage TIII + TIV. E–F Representative images of circARID1A staining in GC tissues at different TNM and T stages. G Expression of circARID1A in GC patients with tumor lengths < 5 cm or ≥ 5 cm. H Expression of circARID1A in GC patients with tumor volumes < 33.3 cm3 or ≥ 33.3 cm3. I ISH analysis of circARID1A expression in GC patients with low or high CD8 expression. J Overall survival analysis of GC patients with low or high expression of circARID1A. The P-values were calculated using the Wilcoxon Signed Rank Test. *P < 0.05